Literature DB >> 18375974

PTPN22 gene polymorphism in Takayasu's arteritis.

N Sahin1, K Aksu, S Kamali, M Bicakcigil, Z Ozbalkan, I Fresko, H Ozer, S Akar, A M Onat, V Cobankara, S Kiraz, M A Oztürk, E Tunç, E Yücel, A Ates, G Keser, M Inanc, H Direskeneli, G Saruhan-Direskeneli.   

Abstract

OBJECTIVE: Takayasu's arteritis (TA) is a chronic, rare granulomatous panarteritis of unknown aetiology involving mainly the aorta and its major branches. In this study, genetic susceptibility to TA has been investigated by screening the functional single nucleotide polymorphism (SNP) of PTPN22 gene encoding the lymphoid-specific protein tyrosine phosphatase.
METHODS: Totally, 181 patients with TA and 177 healthy controls are genotyped by PCR-RFLP method for the SNP rs2476601 (A/G) of PTPN22 gene. Polymorphic region was amplified by PCR and digested with Xcm I enzyme.
RESULTS: Detected frequencies of heterozygous genotype (AG) were 5.1% (9/177) in control group and 3.8% (7/181) in TA group (P = 0.61, odds ratio: 0.75, 95% CI: 0.3, 2.0). No association with angiographic type, vascular involvement or prognosis of TA was observed either.
CONCLUSION: The distribution of PTPN22 polymorphism did not reveal any association with TA in Turkey.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375974     DOI: 10.1093/rheumatology/ken106

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

1.  A PTPN22 promoter polymorphism -1123G>C is associated with RA pathogenesis in Chinese.

Authors:  Jian-Jun Huang; Yu-Rong Qiu; Hai-Xia Li; De-Hua Sun; Jia Yang; Chun-Li Yang
Journal:  Rheumatol Int       Date:  2010-12-31       Impact factor: 2.631

2.  Association of PTPN22 gene polymorphism and systemic lupus erythematosus in a cohort of Egyptian patients: impact on clinical and laboratory results.

Authors:  Pacint Moez; Eiman Soliman
Journal:  Rheumatol Int       Date:  2011-08-05       Impact factor: 2.631

Review 3.  PTPN22: the archetypal non-HLA autoimmunity gene.

Authors:  Stephanie M Stanford; Nunzio Bottini
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

4.  Clinical characteristics and PTPN22 1858C/T variant analysis in Jordanian Arab vitiligo patients.

Authors:  Asem Alkhateeb; Firas Qarqaz; Jude Al-Sabah; Tasnim Al Rashaideh
Journal:  Mol Diagn Ther       Date:  2010-06-01       Impact factor: 4.074

5.  The protein tyrosine phosphatase nonreceptor 22 C1858T polymorphism and vasculitis: a meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2012-06-14       Impact factor: 2.316

6.  No association of PTPN22 gene polymorphism with rheumatoid arthritis in Turkey.

Authors:  N Sahin; F Gunduz; N Inanc; Haner Direskeneli; G Saruhan-Direskeneli
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

Review 7.  Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease.

Authors:  Nunzio Bottini; Erik J Peterson
Journal:  Annu Rev Immunol       Date:  2013-12-18       Impact factor: 28.527

8.  Familial Takayasu's arteritis in female siblings.

Authors:  Jae-Hyeok Heo; Manho Kim
Journal:  Rheumatol Int       Date:  2009-10-25       Impact factor: 2.631

Review 9.  Update on pathogenic mechanisms of systemic necrotizing vasculitis.

Authors:  Maria I Danila; S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

10.  Takayasu's arteritis is associated with HLA-B*52, but not with HLA-B*51, in Turkey.

Authors:  Ziver Sahin; Muge Bıcakcıgil; Kenan Aksu; Sevil Kamali; Servet Akar; Fatos Onen; Omer Karadag; Zeynep Ozbalkan; Askin Ates; Huseyin Te Ozer; Vuslat Yilmaz; Emire Seyahi; Mehmet A Ozturk; Ayse Cefle; Veli Cobankara; A Mesut Onat; Ercan Tunc; Nursen Düzgün; Sibel Z Aydin; Neslihan Yilmaz; İzzet Fresko; Yasar Karaaslan; Sedat Kiraz; Nurullah Akkoc; Murat Inanc; Gokhan Keser; F Aytul Uyar; Haner Direskeneli; Güher Saruhan-Direskeneli
Journal:  Arthritis Res Ther       Date:  2012-02-06       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.